BRPI0906346A2 - "composição farmacêutica de liberação prolongada" - Google Patents

"composição farmacêutica de liberação prolongada"

Info

Publication number
BRPI0906346A2
BRPI0906346A2 BRPI0906346A BRPI0906346A BRPI0906346A2 BR PI0906346 A2 BRPI0906346 A2 BR PI0906346A2 BR PI0906346 A BRPI0906346 A BR PI0906346A BR PI0906346 A BRPI0906346 A BR PI0906346A BR PI0906346 A2 BRPI0906346 A2 BR PI0906346A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
extended release
release pharmaceutical
extended
composition
Prior art date
Application number
BRPI0906346A
Other languages
English (en)
Inventor
John Claude Savoir Vilboeuf
María Teresa De Jesús Francisco Doce
Miriam Villa Vargas
Teresita Del Niño Jesús Costales González
Original Assignee
Posivisionary Solutions Llp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41114143&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0906346(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Posivisionary Solutions Llp filed Critical Posivisionary Solutions Llp
Publication of BRPI0906346A2 publication Critical patent/BRPI0906346A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0906346A 2008-03-28 2009-03-27 "composição farmacêutica de liberação prolongada" BRPI0906346A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
MX2008004268A MX2008004268A (es) 2008-03-28 2008-03-28 Metoclopramida de liberacion prolongada de 24 horas.
PCT/MX2009/000026 WO2009120054A1 (es) 2008-03-28 2009-03-27 Metoclopramida de liberación prolongada de 24 horas

Publications (1)

Publication Number Publication Date
BRPI0906346A2 true BRPI0906346A2 (pt) 2016-07-26

Family

ID=41114143

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0906346A BRPI0906346A2 (pt) 2008-03-28 2009-03-27 "composição farmacêutica de liberação prolongada"

Country Status (9)

Country Link
US (1) US20110033536A1 (pt)
AR (1) AR071571A1 (pt)
BR (1) BRPI0906346A2 (pt)
CA (1) CA2757023C (pt)
CL (1) CL2009000775A1 (pt)
CO (1) CO6311074A2 (pt)
MX (1) MX2008004268A (pt)
PE (3) PE20091737A1 (pt)
WO (1) WO2009120054A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2008004267A (es) * 2008-03-28 2009-09-28 Posi Visionary Solutions Llp Metoclopramida de liberacion prolongada de 12 horas.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2492661A1 (fr) * 1980-10-28 1982-04-30 Laruelle Claude Nouvelle forme galenique d'administration du metoclopramide, son procede de preparation et medicament comprenant cette nouvelle forme
FR2576213B1 (fr) * 1985-01-21 1989-02-24 Cortial Nouveau procede d'obtention de formes pharmaceutiques a liberation prolongee
JPS6261916A (ja) * 1985-09-12 1987-03-18 Fujisawa Pharmaceut Co Ltd 持続性製剤
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
US6372254B1 (en) * 1998-04-02 2002-04-16 Impax Pharmaceuticals Inc. Press coated, pulsatile drug delivery system suitable for oral administration
US6770262B2 (en) * 2000-03-30 2004-08-03 Questcor Pharmaceuticals, Inc. Nasal administration of agents for the treatment of gastroparesis
KR20040106422A (ko) * 2002-05-01 2004-12-17 노파르티스 아게 간암 및 다른 암 질병 치료용 에포틸론 유도체
MY136318A (en) * 2002-07-25 2008-09-30 Pharmacia Corp Sustained-release tablet composition
GB0317904D0 (en) * 2003-07-31 2003-09-03 Jagotec Ag Improvements in or relating to organic compounds

Also Published As

Publication number Publication date
US20110033536A1 (en) 2011-02-10
CA2757023C (en) 2017-09-05
MX2008004268A (es) 2009-09-28
AR071571A1 (es) 2010-06-30
CA2757023A1 (en) 2009-10-01
CL2009000775A1 (es) 2009-09-25
WO2009120054A1 (es) 2009-10-01
PE20091737A1 (es) 2009-11-25
PE20141001A1 (es) 2014-08-25
PE20091824A1 (es) 2009-11-25
CO6311074A2 (es) 2011-08-22

Similar Documents

Publication Publication Date Title
LTPA2018014I1 (lt) Farmacinė kompozicija 514
LTC2140867I2 (lt) Farmacinė kompozicija
BRPI0810928A2 (pt) "composição farmacêutica"
BRPI0913806A2 (pt) "composição"
BRPI0721651A2 (pt) Composição farmacêutica
BRPI0910229A2 (pt) Tetramatos de 4';4'-dioxaspiro espirociclicamente substituídos
BRPI0916123A2 (pt) "composição de xampu concentrada"
BRPI0922904A2 (pt) "compostos"
BRPI0715712A2 (pt) Composição farmacêutica
BRPI0913379A2 (pt) formulações farmacêuticas sólidas compreendendo bibw 2992
DK3492069T3 (da) Farmaceutiske sammensætninger omfattende jern-oxy-hydroxid
BRPI0908596A2 (pt) formulação e composição farmacêutica de liberação prolongada
BRPI0914375A2 (pt) ''composições antiperspirantes''
BRPI0719393A2 (pt) Composição farmacêutica
DK2120884T3 (da) Farmaceutisk sammensætning
BRPI0716445A2 (pt) composiÇço farmacÊutica
DK2285413T3 (da) Farmaceutisk sammensætning
BRPI0720234A2 (pt) Composição farmacêutica
BRPI0914503A2 (pt) "composição de shampoo concentrado"
DK2285357T3 (da) Farmaceutisk sammensætning omfattende brivaracetam
BRPI0921313A2 (pt) composição farmaucêutica
BRPI0820198A2 (pt) composições farmacêuticas
BRPI0912171A2 (pt) composição farmacêutica
BRPI0913425A2 (pt) formulações de niacina com liberação modificada
DK2271321T3 (da) Farmaceutisk sammensætning 271

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]